chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sudden onset of chest pain. Positive vomiting. Duration of 3 hours prior to arrival of emergency department. Nausea, vomiting, fatigue, day prior.
RISE IN TEMPERATURE; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced rise in temperature. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) Raised. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of rise in temperature was not reported. This report was non-serious. This case, from the same reporter is linked to 20210847388.
eyelids inflammation/eyelids are inflammed; eyelids burning; This spontaneous case was reported by a consumer and describes the occurrence of BLEPHARITIS (eyelids inflammation/eyelids are inflammed) and EYELID IRRITATION (eyelids burning) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLEPHARITIS (eyelids inflammation/eyelids are inflammed) and EYELID IRRITATION (eyelids burning). At the time of the report, BLEPHARITIS (eyelids inflammation/eyelids are inflammed) and EYELID IRRITATION (eyelids burning) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided by the reporter.  No treatment medication was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Significant follow up received and New event added.
Information has been received from a pharmacist regarding her son and from the child's physician concerning a 34 month old male with no past medical history who on 05/14/1999 at one year old was vaccinated in the right arm with a first dose of varicella vaccine, a first dose of MMR in the left arm and a dose of oral polio. there was no illness at the time of vaccination. On 03/23/2001 the child broke out with "rash/crusted lesion" on his right arm which the mother described as "shingles." The mother was told it was the "C 6 nerve." Subsequently, the pt recovered within one week. The physician provided follow-up info stating the pt's experience was a "vesicular rash, right arm in the C6 dermatome, likely shingles." The pt sought unspecified medical attention and was seen at the doctor's office on 03/26/2001. It was noted that the pt recovered.
I have a rash at the point of injection of the lower injection site (I think it is where the shingles vaccine was injected.) It is quarter sized and appeared yesterday evening. I applied NEOSPORIN and so far it itches but has not spread. Pt 4/11/17 secure msg.
Description of adverse event - Upon disrobing in order to shower for the evening, I noticed a rash, primarily on my torso, but also on my arms. I had not noticed it before this time. I had not noticed itching or any other side effects other than the (expected) arm pain.  Treatment - 50 mg of Benadryl  Outcome - rash is still present at this time (11:05 PM, Monday 2/8)
They both agree that they want to stop all life saving or sustaining efforts at this time including fluids and would like to remove the Bipap. They agreed to using a HFNC for patient comfort and to reduce air hunger. Notified by RN that patient was unresponsive. Patient was found to be breathless, pulseless and without a BP. RN had already attempted to call her children and was unable to reach them. He was able to reach her granddaughter to notify her of the patient's passing. Patient was pronounced dead at 0154 11/17/22. Health officials and ME to be contacted by house supervisor.
Fatigue day one, worse day 3. Headache, nausea, vomiting day 3.
This spontaneous report was received from a Licensed Practical Nurse, concerning unspecified number of patients of unknown age and gender. There were no concurrent conditions, medical history, drug reactions, allergies or concomitant medications reported. On unspecified dates, the patients were vaccinated with improperly stored doses of ZOSTAVAX (dose, frequency and route were not reported) lot # M011665 with expiration date of 17-MAY-2017 and lot # reported as M041182 with expiration date of 04-JUN-2018, for prophylaxis. The sterile diluents (lot # and expiration date were not reported) used to reconstitute the ZOSTAVAX were properly stored. The temperature excursion of the ZOSTAVAX was between 6°F and 14°F for a time frame of 18 hours and 15 minutes. No previous temperature incursion was reported. No adverse effects were reported. Data logger was involved. Additional information has been requested. Sender's Comments: US-009507513-1705USA001705: US-009507513-1705USA004703.
9 days later! I have a red, itchy, urticarial reaction at the site of the  vaccine injection  - left arm. No problem before that.
topical irritation; fast beating heart; shortness of breath; Experience brief chest pain like my heart ache, little bit in my upper back and it is not consistent like I am going to watch every minute; Experience brief chest pain like my heart ache, little bit in my upper back and it is not consistent like I am going to watch every minute; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 04Aug2021 as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced topical irritation, fast beating heart, shortness of breath, "experience brief chest pain like my heart ache, little bit in my upper back and it is not consistent like i am going to watch every minute" on Aug2021. Reported as, patient received the vaccine counting today 3 days ago on 04Aug Wednesday and don't know patient have like topical irritation or fast beating heart or shortness of breath anything but have experience like brief chest pain like his heart ache and little bit in his upper back and again it was not like consistent, like patient was going to watch every minute and it's more sort of, it will go in and out. The patient underwent lab tests and procedures which included heart rate: fast on Aug2021. Outcome of all the events were unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This is a spontaneous report from a Pfizer-sponsored program, from a contactable Pharmacist. A 69-year-old female patient received PREVNAR 13 (Lot # S51635, Expiry Date Oct2018, NDC # 00005197102) intramuscular at 0.5ml IM injection in left deltoid on 20Oct2017 for immunization, administered under protocol for pharmacy at Pharmacy/Drug store. The patient medical history and concomitant medications were not reported. Prior Vaccinations within 4 weeks included: influenza vaccine (FLU SHOT, Sanofi; Lot # UI867AC) IM at right arm administered the week before the suspect vaccination in Oct2017 for immunization. Additional vaccines administered on same date of the Pfizer suspect were none. History of all previous immunization with the Pfizer vaccine considered as suspect was none. The patient experienced arm was hot to touch on an unspecified date with outcome worsened, injections site was bright red and more than 7cm on an unspecified date with outcome worsened, soreness in left arm at injection site on 21Oct2017 with outcome of unknown (but patient still could work). The events did not require a visit to Emergency Room or Physician office. No relevant tests performed. The reporter considered injections site was more than 7cm a severe reaction. The reporter considered the events were related to PREVNAR 13. Amendment: This follow-up report is being submitted to amend previously reported information. The case is being assessed by Company Physician. Sender's Comments: The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, as appropriate. The case will be reassessed if additional information becomes available.
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare facility consulted with the regulatory authority and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare facility is working with the regulatory authority  on a compliance improvement plan and has been reinstated vaccination privileges.
None of my family have been sick this whole time and then we went out of town on the plane and were masked. We all got our vaccines at the same time and all got sick. My daughter first tested positive, then my husband and I were positive on the 2nd. So we went to Urgent Care. The symptoms I had were little bit of the runs, I started coughing almost like a bronchial infection. I had a little headache. They gave me Paxlovid and my pill was this morning. I've had fatigue but I  also have chronic anemia. I'm still raspy in my lungs. Otherwise I'm fine.
Patient wasnt sure what type of Flu shot it was... she stated that it wasn't the high dose...after an hour of getting the vaccine she stated that her rate increase rapidly
Drippy nose almost 24 hours after vaccine injection followed by itchiness around mouth and nose for several hours. Took one antihistamine--chlorpheniramine. Began to feel chills 29 hours after injection. 36 hours after injection, awakened when both arms and legs felt numb. Very thirsty, 'cotton mouth'. Drank water. Will take another chlorpheniramine.
Costochondritis, continuing after 2 weeks and following high fever and chills from vaccine.
PATiENT DEVELOPED MYALGIAS, NAUSEA + DiZZiNESS WHILE SITTING ABOUT 6 HOURS AFTER RECEIPT OF COVID BIVALENT VACCINE + SYNCOPE, SEEN IN ER + AT CLINIC HEALTH
Staff reported a fine maculopapular rash over both cheeks on face, chin, and forehead - no vesicles, induration or pruritus - afebrile (reported on 1-5-14). No treatment was ordered. Rash began to fade on 1-8-14 and was almost gone on 1-9-14.
Difficulty with moving arm > than 45 degree angle. Pain under armpit. Can't lay on side. Difficulty dressing & driving. Started aching that day but slowly got worse. TYLENOL & Ibuprofen ineffective. Pt says was RN and shot administered in "joint".
Fever of 102 on 7-10-13. Fever reducing meds given. On July 27th patient starting having muscle weakness and lasted for 3 wks.
I began to feel tired, body aches, moderate  to severe pain in arm and very lethargic about two hours after receiving the vaccines.  Based on the information sheet from the CDC, I am confident this is probably from the Shingrix, vaccine rather than the Typhoid vaccine. Since I had them both at the same time in the same arm, it is hard to absolutely confirm which vaccine caused these symptoms.
Pt reported "pink eye," shortness of breath "fluid in lung" to the physician on 05/03/2002. Physician prescribed 7 medications during the next two weeks. Pt states she felt improvement during the first week. A follow-up appointment with rheumatologist indicated the pt should never have vaccines again.
PM of injection pain & swelling. Still red & swelling & bump on 3rd day, still sore 10/19 but decreasing left arm.
Pt returned to clinic 3 days later c/o redness and itchiness at the site of injection. She states it started 12 hours post injection. Redness has progressively spread down (L) arm to (L) elbow.
No additional AE; expired VAQTA was administered; This spontaneous report was received from a registered nurse referring to an adult patient of unknown gender.   No information was provided regarding the patient's medical history, concurrent conditions, past drug history or concomitant medications  On 15-NOV-2021, the patient was vaccinated with hepatitis A vaccine, inactivated (VAQTA) pre-filled syringe, lot # T017179, 1 milliliter, for prophylaxis (route and site of administration were not reported).    According to the reporter, the vaccine expired on 26-OCT-2021 (expired product administered).  The vaccine did not have any temperature excursions.  No adverse events or product quality complains were reported (no adverse event).
few mins after vaccine, felt clammy, dizzy. staff notified, assisted patient to floor to put feet on chair. few mins later assisted to stretcher and taken to obs. in trendelenberg. states was anxious about vaccine. bp 155/71 hr 86 rr 20 sats 95%. water and snacks provided, sat up, bp 172/68 hr 86, rr 18, sats 98% on ra; stated he hadnt taken his noon lisinopril yet and still pretty anxious. after resting, bp 167/81 hr 87, requesting to leave with spouse. escorted to exit with no further issues, instructed to take lisinopril once home.
Extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Extremely tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Extremely tired). At the time of the report, FATIGUE (Extremely tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 17-Aug-2021: Telephone Contact Report received and the reporter declined for further follow up.
This case was reported by a nurse and described a patient who did not respond to immunization with hepatitis B vaccine recombinant (Engerix B). On an unspecified date, the patient received the third dose of Engerix B (lot AHBV032AA incorrect lot number). At an unspecified time following the third dose of Engerix B. on Feb 18 2005, a hepatitis B surface antibody titer was negative. On March 2 2005, the patient received the fourth dose of Engerix B (lot AHBV032AA incorrect lot number). Approximately 30 days after the fourth dose of Engerix B, on April 1 2005, a hepatitis B surface antibody titer was negative.
blood clot on the left leg; blood clot on the right leg; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (blood clot on the right leg) and THROMBOSIS (blood clot on the left leg) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038321A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced THROMBOSIS (blood clot on the right leg) (seriousness criterion medically significant). On 12-Apr-2021, the patient experienced THROMBOSIS (blood clot on the left leg) (seriousness criterion medically significant). At the time of the report, THROMBOSIS (blood clot on the right leg) and THROMBOSIS (blood clot on the left leg) outcome was unknown. Not Provided   The patient has not provided with any concomitant medication. No treatment medications are listed.  Company Comment  Based on the current available information which includes a strong temporal association between the use of mRNA-1273 vaccine and onset of the reported events, a causal relationship cannot be excluded.   This case was linked to US-MODERNATX, INC.-MOD-2021-043122 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-043122:1st dose
9 day old baby came in for first visit. Was going to grab the Hepatitis B vaccine and mistakenly grabbed the FLUARIX 0.5 ml vaccine. I did not realize it at that time but about 20-30 minutes later I called CDC info and state Health Department. Called father with what had happened and information given to us.
Blisters cluster around nose, mouth and underneath on one side of my face; Puffiness; Feel like bump underneath my nose and eyes; Feel like bump underneath my nose and eyes; Soreness in mouth; Cold sores; stomach ache; headache; sore arms; This is a spontaneous report from a contactable consumer (patient, self-reported) via Pfizer-sponsored program COVAX Support. A 62-year-old female reported received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL3249 and expiry date was not reported), via an unspecified route of administration, on 19Feb2021 (age at the vaccination 62-year-old) as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history included cancer. Concomitant medications included Ativan (Lorazepam), levothyroxine sodium (SYNTHROID), paracetamol (Tylenol) and ascorbic acid, ergocalciferol, nicotinamide, retinol, riboflavin, thiamine hydrochloride (VITAMINS). Patient gotten her first shot on a week ago today and on Monday patient had experienced blisters that started around my nose and around by my mouth, a cluster of them, some are away from each other but others they are in a cluster and a little bit of underneath on one side of my face, little bit of puffiness and patient feel like there is a bump underneath kind of by her nose by her eyes. There was a lot of "around in" (not clarified) soreness in her mouth on 22Feb2021. The patient stated that, well right now she was taking the Sab a little Sab for cold sores on 22Feb2021. She stated that, she was generally immune compromised because I have had cancer in the past but other than that no. The patient stated, she only took things for her stomach like she did not know. Basically, she took Tylenol as she needed, she took Vitamins things like that. She also took smallest the dose that is 0.5 of Ativan half (not clarified) of that, before she goes to bed. She also takes Synthroid for her thyroid and also patient experienced blisters, headache, stomach-ache and sore arms after the 1st dose on an unspecified date in 2021. consumer stated, she just did her lab test Monday (not clarified): Unknown result on 22Feb2021. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Patient experienced a Herpes Zoster rash within 36 hours of receiving a Zostavax vaccination. Rash enlarged and spread over right side of back, under arm and across chest for three more days before beginning to heal and recede. Injection was administered in right deltoid.
This spontaneous report was received from a pharmacist, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies and drug or allergy reactions were not provided. On 18-SEP-2018, the patient was vaccinated with a improperly stored dose of PNEUMOVAX 23 lot number R005345, expiration date 01-MAR-2020 (strength, dose, dose number and administration route were not reported), for prophylaxis. The data logger registered a temperature excursion below 0 Celsius (C) for 41 hours and 0 C to 1 C for 49 hours. There was not previous temperature excursion. No adverse effects were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1809USA009938.
The COVID  vaccine (expiration of 2/28/22) was given after it's beyond use date of 1/15/2022. Outcomes of giving the vaccine after the BUD unknown.
ST elevation myocardial infarction involving right coronary artery. Today PVC's still bi and trigeminal. Will discharge with holter to assess burden. He will stay on coreg 12.5 mg BID instead of metoprolol. INR is still subtherapeutic so he will be bridged with lovenox so he can be discharged. He will continue entresto, aspirin, plavix, and warfarin. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
pt recvd vax at 1pm;approx 3:45pm started v,turned pale,listless,high pitched cry;to MD,BP high 110/90;hypotonia & lethargy;noted to be fretful;
Patient received Fluarix vaccine at our vaccine clinic, but she had already received a Fluad 65+ vaccination on 9-14-23 No known side effects or problems known  as of 10-20-23  Advised to follow up with her healthcare provider
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 43-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19 which includes a Pfizer brand Covid-19 treatment from 01Oct2022 to unspecified date in Oct2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.